|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 螺内酯与可乐定作为难治性高血压第4种治疗药物的比较:难治性高血压的最佳治疗随机研究显示文摘该研究旨在通过一个多中心随机试验对作为难治性高血压患者的第4种治疗药物的螺内酯与可乐定进行比较。采用药丸计数评估药物治疗依从性。难治性高血压患者(定义为包括1种利尿剂在内的3种药物治疗12周,诊室及动态血压监测血压仍未控制)随机给予螺内酯(12.5~50 mg/d)或可乐定(0.1~0.3mg,2次/d)继续治疗12周。 | Krieger EM Drager LF Giorgi DMA Pereira AC Barreto-Filho JAS Nogueira AR Mill JG Lotufo PA Amodeo C Batista MC Bodanese LC Carvalho ACC Castro I Chaves H Costa EAS Feitosa GS Franco RJS Fuchs FD Guimarāes AC Jardim PC Machado CA Magalhāes ME Mion D Jr Nascimento RM Nobre F Nóbrega AC Ribeiro ALP Rodrigues-Sobrinho CR Sanjuliani AF Teixeira MDCB Krieger JE ReHOT Investigators 赵狄 练桂丽 | 2018 | 中华高血压杂志2018，26，3： | 7 |
| 2 | In vitro activity of five β-lacfam/β-laclamase inhibitor combinations against consecu-tive isolates of the enlerobacteracoae and pesudomonesaeruginos显示文摘 | McIaughlrn JC Barry AL Fuchs PC | 1994 | Antimicrob Chemother1994，33，： | 1 |
| 3 | Daptomycin susceptibility tests:inter- pretive criteria, quality control, and effect of calcium on in vitro tests 显示文摘 | Fuchs PC Barry AL Brown SD | 2000 | Diagn microbial Infect Dis2000，38，1： | 1 |
| 4 | In-vitro activity of five β-lactam/ β -lactamase inhibitor combinations against consecutive, isolates of the enterobacteriaceae and pseuolomohsa aeruginose显示文摘 | Mclaughln JC Barry AL Fuchs PC | 1994 | J Antimicrob Chemother1994，33，： | 1 |
| 5 | NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘 | Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C | 2009 | J Natl Compr Canc Netw2009，7，： | 1 |
| 6 | In vitro activities of sparfloxacin, tosuflox acin, ciprof loxacin, and fleroxacin显示文摘 | Barry AL Fuchs PC | 1991 | Antimicrob Agents Chemother1991，35，5： | 1 |
| 7 | In vitro activity of piperacillin/tazobactam: a review显示文摘 | Barry AL | 1993 | Complication Surg1993，12，： | 1 |
| 8 | In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers显示文摘 | Fuchs PC Barry AL Brown SD | 2001 | Antimicrob Agents Chemother2001，45，6： | 1 |
| 9 | The ALT chimera flap : expanding the indications 显示文摘 | Fuchs PC Wolter TP Pallua N | 2010 | Eur J Plast Surg2010，33，2： | 1 |
| 10 | Comparative in vitro antimicrobial activity of a new carbapenem,E1010,and tentative disc diffusion test interpretative criteria显示文摘 | Fuchs PC Barry AL Brown SD | 2001 | J Antimicrob Chemother2001，48，1： | 1 |
| 11 | In vitro activity of piperacillin/tazobactam: A review显示文摘 | Fuchs PC Barry AL | 1993 | Complications in surgery1993，12，： | 1 |
| 12 | In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers显示文摘 | Barry AL Brown SD | 2001 | Antimicrob Agents Chemother2001，45，： | 1 |
| 13 | Enhanced dermal regeneration using modified collagen scaffolds:experimental porcine study 显示文摘 | Markowicz MP Steffens GC Fuchs PC | 2006 | Int J Artif Organs2006，29，： | 1 |
| 14 | Interpretive criteria for antimicmbial suscepti-bility tests with cefodizime discs显示文摘 | Fuchs Pc Barry AL | 1991 | J Antimicrob Chemother1991，27，6： | 1 |
| 15 | In-vitro activity of five β-Lactam/β-Lactamase inhibitor combinations against consecutive, isolates of the enterobacteriaceae and pseudomonas显示文摘 | Mclaughlin JC Barry AL Fuchs PC | 1994 | J Antimicrob Chemother1994，33，： | 1 |
| 16 | Cefmenoxime(SCF-1365),a new cephalosporin:in vitro activity,comparison with other antimicrobial agents,beta-lactamase stability,and disk diffusion testing with tentative interpretive criteria显示文摘 | Fuchs PC Jones RN Thornsberry C Barry AL Gerlach EH Sommers HM | 1981 | Antimicrob Agents Chemother1981，20，： | 1 |
| 17 | Intra-alveolar IL-6 levels following burn and inhalation injury 显示文摘 | Fuchs PC Demir E Reuber K | 2009 | Bums2009，35，6： | 1 |
| 18 | MRSA-retrospective analysis of an outbreak in the burn centre Aachen显示文摘 | Fuchs PC Kopp J Hafner H | 2002 | Burns2002，28，6： | 1 |
| 19 | Interpretative criteria and quality control parameters for telithromyein disc diffusion susceptibility tests显示文摘 | Barry AL Fuchs PC Brown SD | 2001 | J AntimierobChemother2001，48，1： | 1 |
| 20 | Streptococcus pneumonial killing rate and postantibiotic effect of levofloxacin and ciprofloxacin 显示文摘 | Fuchs PC Barry AL Brown SD | 1997 | J Chemother1997，9，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员